Tyk2 is a tumor suppressor in colorectal cancer-Reference-Cited by-同舟云学术

Tyk2 is a tumor suppressor in colorectal cancer

Published:2022-09-26 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Moritsch Stefan¹,Mödl Bernadette¹,Scharf Irene¹,Janker Lukas²³,Zwolanek Daniela¹,Timelthaler Gerald¹,Casanova Emilio⁴,Sibilia Maria¹,Mohr Thomas¹,Kenner Lukas⁵,Herndler-Brandstetter Dietmar¹,Gerner Christopher²³,Müller Mathias⁶,Strobl Birgit⁶,Eferl Robert¹^ORCID

Affiliation:

1. Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center, Vienna, Austria

2. Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria

3. Joint Metabolomics Facility, University and Medical University of Vienna, Vienna, Austria

4. Department of Pharmacology, Center of Physiology and Pharmacology & Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

5. Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria

6. Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria

Funder

Austrian Science Fund (FWF) SFB F6106 Doktoratskolleg-plus

FWF standalone

Fellinger Cancer Research Foundation

FWF special research program

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2127271

Reference79 articles.

1. Cancer statistics, 2022

2. Cancers Complicating Inflammatory Bowel Disease

3. Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

4. Incidence and Mortality of Colorectal Adenocarcinoma in Persons With Inflammatory Bowel Disease From 1998 to 2010

5. Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship Between Serum and Tissue Levels of IL-13 and TYK2 in Colorectal Cancer Patients;Immunological Investigations;2024-09-09

2. Molecular Characteristics of TYK2 Gene Expressions in Patients with Colorectal Cancer;Advanced Biomedical Research;2023-11

3. Murine models of colorectal cancer: the azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis-associated cancer;PeerJ;2023-10-31